Poster
Sofia Mallorquí Alcalá, MSc
PhD student
Vall d'Hebron Institute of Oncology (VHIO)
Barcelona, Catalonia, Spain
Iñaki Salvador, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Barcelona, Catalonia, Spain
Carlos Palacio
Department of Hematology, Vall d´Hebron University Hospital, Barcelona, Spain
Barcelona, Catalonia, Spain
Miguel Bastos-Boente, PhD candidate
PhD Candidate
Servicio de Hematología, Hospital Universitario de Salamanca (HUS – IBSAL), CIBERONC y Centro de Investigación del Cáncer de Salamanca – IBMCC (CIC – USAL)
Salamanca, Castilla y Leon, Spain
Miguel Alcoceba, PhD
Head of Department
Servicio de Hematología, Hospital Universitario de Salamanca (HUS – IBSAL), CIBERONC y Centro de Investigación del Cáncer de Salamanca – IBMCC (CIC – USAL)
Salamanca, Castilla y Leon, Spain
Cristina de Ramón, MD
University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)
Salamanca, Castilla y Leon, Spain
Almudena Navarro, MD, PhD
University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC)
Salamanca, Castilla y Leon, Spain
Daniel Medina-Gil, MSc
PhD student
Vall d'Hebron Institute of Oncology (VHIO)
Barcelona, Catalonia, Spain
Maite Erguin, MSc
Vall d'Hebron Institute of Oncology (VHIO)
Barcelona, Catalonia, Spain
Patricia Fernández-Guzmán, MSc
PhD student
Vall d'Hebron Institute of Oncology (VHIO)
Barcelona, Catalonia, Spain
Ángel Serna, MD
Department of Hematology, Vall d´Hebron University Hospital
Barcelona, Catalonia, Spain
Pau Abrisqueta, MD, PhD
Hematologist
Department of Hematology, Vall d´Hebron University Hospital
Barcelona, Catalonia, Spain
Francesc Bosch, MD, PhD
Head, Dept of Hematology; Director, Experimental Hematology (VHIO); Professor
Universtitat Autonoma Barcelona, Hospital Universitari Vall d'Hebron
Barcelona, Catalonia, Spain
Marta Crespo, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Barcelona, Catalonia, Spain